ATE479705T1 - Reduzierter slam abhängiger zell eintritt - Google Patents
Reduzierter slam abhängiger zell eintrittInfo
- Publication number
- ATE479705T1 ATE479705T1 AT03728658T AT03728658T ATE479705T1 AT E479705 T1 ATE479705 T1 AT E479705T1 AT 03728658 T AT03728658 T AT 03728658T AT 03728658 T AT03728658 T AT 03728658T AT E479705 T1 ATE479705 T1 AT E479705T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- slam
- reduced
- dependent cell
- viruses
- Prior art date
Links
- 230000001419 dependent effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 241000700605 Viruses Species 0.000 abstract 4
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108010093857 Viral Hemagglutinins Proteins 0.000 abstract 1
- 230000008629 immune suppression Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
- C12N2760/18443—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Transducers For Ultrasonic Waves (AREA)
- Radar Systems Or Details Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Primary Cells (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37768102P | 2002-05-03 | 2002-05-03 | |
| PCT/US2003/013679 WO2003093431A2 (en) | 2002-05-03 | 2003-05-02 | Ablated slam-dependent entry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479705T1 true ATE479705T1 (de) | 2010-09-15 |
Family
ID=29401550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03728658T ATE479705T1 (de) | 2002-05-03 | 2003-05-02 | Reduzierter slam abhängiger zell eintritt |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7635752B2 (de) |
| EP (1) | EP1549672B1 (de) |
| AT (1) | ATE479705T1 (de) |
| AU (1) | AU2003234342A1 (de) |
| DE (1) | DE60334008D1 (de) |
| WO (1) | WO2003093431A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1793875B9 (de) * | 2004-06-16 | 2010-09-08 | Affinergy, Inc. | Grenzflächenbiomaterialien zur förderung der anhaftung von zielanalyten |
| EP1975239A1 (de) * | 2006-09-27 | 2008-10-01 | Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer | Pseudotyping von retroviralen Vektoren, Methoden zu deren Produktion und deren Verwendung für zielgerichteten Gen Transfer und screening Methoden |
| WO2009117307A2 (en) | 2008-03-21 | 2009-09-24 | Mayo Foundation For Medical Education And Research | Viruses lacking epithelial cell receptor entry |
| EP2494978A1 (de) * | 2011-03-03 | 2012-09-05 | Bundesrepublik Deutschland, Letztvertreten Durch Den Präsidenten Des Paul-Ehrlich-Instituts | Verbesserte Tumortherapie bei Tumorstammzellen angreifenden onkolytischen Viren |
| ES3052812T3 (en) | 2017-05-08 | 2026-01-14 | Flagship Pioneering Innovations V Inc | Compositions for facilitating membrane fusion and uses thereof |
| EP4494651A3 (de) | 2017-05-16 | 2025-08-27 | Mayo Foundation for Medical Education and Research | Modifizierte viren |
| WO2020230785A1 (ja) | 2019-05-14 | 2020-11-19 | 国立大学法人鳥取大学 | 細胞融合を誘導するワクシニアウイルス及びその利用 |
| PH12022550836A1 (en) * | 2019-10-09 | 2023-10-09 | Mayo Found Medical Education & Res | Canine distemper virus hemagglutinin and fusion polypeptides |
| EP4249596A4 (de) | 2020-11-17 | 2025-03-12 | National University Corporation Tottori University | Neues genrekombinantes vacciniavirus und verwendung davon |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| AU7607900A (en) | 1999-09-22 | 2001-04-24 | Mayo Foundation For Medical Education And Research | Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| US7118740B1 (en) * | 2000-09-22 | 2006-10-10 | Mayo Foundation For Medical Education And Research | Method for limiting the growth of cancer cells using an attenuated measles virus |
-
2003
- 2003-05-02 DE DE60334008T patent/DE60334008D1/de not_active Expired - Lifetime
- 2003-05-02 US US10/512,627 patent/US7635752B2/en active Active
- 2003-05-02 EP EP03728658A patent/EP1549672B1/de not_active Expired - Lifetime
- 2003-05-02 WO PCT/US2003/013679 patent/WO2003093431A2/en not_active Ceased
- 2003-05-02 AU AU2003234342A patent/AU2003234342A1/en not_active Abandoned
- 2003-05-02 AT AT03728658T patent/ATE479705T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20050271621A1 (en) | 2005-12-08 |
| AU2003234342A1 (en) | 2003-11-17 |
| EP1549672B1 (de) | 2010-09-01 |
| WO2003093431A2 (en) | 2003-11-13 |
| DE60334008D1 (de) | 2010-10-14 |
| AU2003234342A8 (en) | 2003-11-17 |
| WO2003093431A3 (en) | 2004-07-15 |
| EP1549672A2 (de) | 2005-07-06 |
| EP1549672A4 (de) | 2008-11-26 |
| US7635752B2 (en) | 2009-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1442058T3 (da) | Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler | |
| BR0211199A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| BRPI0412845A (pt) | herpes-vìrus, uso de um vìrus, composição farmacêutica, e, método de tratamento de um tumor em um indivìduo em necessidade do mesmo | |
| NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
| DE60236864D1 (de) | Chimere alphavirus-replikon-partikel | |
| NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
| CY1118171T1 (el) | Θεραπευτικη αντιμετωπιση της φαiνυλκετονουρiας me βη4 | |
| CY1112055T1 (el) | Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα | |
| NO20075815L (no) | Formuleringer og metoder for behandling av amyloidose | |
| BR0209990A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| DE60327999D1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| DE60334008D1 (de) | Reduzierter slam abhängiger zell eintritt | |
| DK1368054T3 (da) | Anvendelse af neurale trådproteiner til behandling af tumorer | |
| NO20032818L (no) | Polypeptider | |
| DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
| IS2889B (is) | Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun | |
| NO20051561L (no) | Nukleinsyremolekyler som koder for humant papillomavirus og anvendelse av disse i vaksine. | |
| ATE480630T1 (de) | Methode zur herstellung von viralen partikeln welche eine veränderte zellbindungsaktivität haben und deren verwendungen | |
| ATE395935T1 (de) | An der oberfläche von karzinomzellen lokalisiertes colligin/hsp47 | |
| ATE255594T1 (de) | Hepatitis b inhibitoren | |
| DE60230641D1 (de) | Lentivirale vektoren zur behandlung von schmerzen | |
| DE60018964D1 (de) | Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen | |
| DK1339737T3 (da) | Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus | |
| ATE528392T1 (de) | Neues protein und dessen dns | |
| DE50200757D1 (de) | Verwendung von tryptophan-derivaten zur spezifischen zytostatischen behandlung von serotonin-produzierenden tumoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |